These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8223475)

  • 1. Transcription enhancer factor-1 (TEF-1) DNA binding sites can specifically enhance gene expression at the beginning of mouse development.
    Mélin F; Miranda M; Montreau N; DePamphilis ML; Blangy D
    EMBO J; 1993 Dec; 12(12):4657-66. PubMed ID: 8223475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of transcription factors binding to the duplicated PEA1 and PEA3 sites that are required for polyomavirus mutant expression in PCC4 embryonic carcinoma cells.
    Nothias JY; Weinmann R; Blangy D; Melin F
    J Virol; 1993 Jun; 67(6):3036-47. PubMed ID: 8388487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The need for enhancers in gene expression first appears during mouse development with formation of the zygotic nucleus.
    Martínez-Salas E; Linney E; Hassell J; DePamphilis ML
    Genes Dev; 1989 Oct; 3(10):1493-506. PubMed ID: 2558965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The need for enhancers is acquired upon formation of a diploid nucleus during early mouse development.
    Martínez-Salas E; Cupo DY; DePamphilis ML
    Genes Dev; 1988 Sep; 2(9):1115-26. PubMed ID: 2847960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.
    Ishiji T; Lace MJ; Parkkinen S; Anderson RD; Haugen TH; Cripe TP; Xiao JH; Davidson I; Chambon P; Turek LP
    EMBO J; 1992 Jun; 11(6):2271-81. PubMed ID: 1318197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of proteins binding to the F441 locus of polyomavirus B enhancer that are required for its activity in embryonic carcinoma cells.
    DasGupta S; Shivakumar CV; Das GC
    J Gen Virol; 1993 Apr; 74 ( Pt 4)():597-605. PubMed ID: 8385690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activity in 3T3, F9, and PCC4 embryonal carcinoma cells: a systematic deletion and linker-scanning study of the polyomavirus enhancer.
    Trotot P; Mechali F; Blangy D; Lacasa M
    Virology; 1994 Aug; 202(2):724-34. PubMed ID: 8030236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel family of developmentally regulated mammalian transcription factors containing the TEA/ATTS DNA binding domain.
    Jacquemin P; Hwang JJ; Martial JA; Dollé P; Davidson I
    J Biol Chem; 1996 Sep; 271(36):21775-85. PubMed ID: 8702974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a large bent DNA domain and binding sites for serum response factor adjacent to the NFI repeat cluster and enhancer region in the major IE94 promoter from simian cytomegalovirus.
    Chang YN; Jeang KT; Chiou CJ; Chan YJ; Pizzorno M; Hayward GS
    J Virol; 1993 Jan; 67(1):516-29. PubMed ID: 8380090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3.
    Yuan H; Corbi N; Basilico C; Dailey L
    Genes Dev; 1995 Nov; 9(21):2635-45. PubMed ID: 7590241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. trans activation of the simian virus 40 late promoter by large T antigen requires binding sites for the cellular transcription factor TEF-1.
    Casaz P; Sundseth R; Hansen U
    J Virol; 1991 Dec; 65(12):6535-43. PubMed ID: 1658359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental acquisition of enhancer function requires a unique coactivator activity.
    Majumder S; Zhao Z; Kaneko K; DePamphilis ML
    EMBO J; 1997 Apr; 16(7):1721-31. PubMed ID: 9130716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human placental TEF-5 transactivates the human chorionic somatomammotropin gene enhancer.
    Jiang SW; Wu K; Eberhardt NL
    Mol Endocrinol; 1999 Jun; 13(6):879-89. PubMed ID: 10379887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays.
    Feuer G; Taketo M; Hanecak RC; Fan H
    J Virol; 1989 May; 63(5):2317-24. PubMed ID: 2704078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and mutational analysis of the polyomavirus core promoter: involvement of nuclear factor-1 in early promoter function.
    Shivakumar CV; Das GC
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1281-90. PubMed ID: 8207394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distal enhancer of the mouse FGF-4 gene and its human counterpart exhibit differential activity: critical role of a GT box.
    Boer B; Luster TA; Bernadt C; Rizzino A
    Mol Reprod Dev; 2005 Jul; 71(3):263-74. PubMed ID: 15803454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human chorionic somatomammotropin gene enhancer activity is dependent on the blockade of a repressor mechanism.
    Lytras A; Cattini PA
    Mol Endocrinol; 1994 Apr; 8(4):478-89. PubMed ID: 8052268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between T antigen and TEA domain of the factor TEF-1 derepresses simian virus 40 late promoter in vitro: identification of T-antigen domains important for transcription control.
    Berger LC; Smith DB; Davidson I; Hwang JJ; Fanning E; Wildeman AG
    J Virol; 1996 Feb; 70(2):1203-12. PubMed ID: 8551581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription.
    Chong T; Apt D; Gloss B; Isa M; Bernard HU
    J Virol; 1991 Nov; 65(11):5933-43. PubMed ID: 1656080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of transcriptional enhancer factor-1 and activator protein-1-dependent enhancer activity by vascular actin single-stranded DNA binding factor 2.
    Kelm RJ; Sun S; Strauch AR; Getz MJ
    J Biol Chem; 1996 Sep; 271(39):24278-85. PubMed ID: 8798674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.